Home LiteratureArticle Details
PMID: 18948634 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

High-density lipoproteins affect endothelial BMP-signaling by modulating expression of the activin-like kinase receptor 1 and 2.

Arteriosclerosis, thrombosis, and vascular biology ·Vol. 28 ·No. 12 ·2008-12-00 ·Pages 2266-74

Yao Y, Shao ES, Jumabay M, Shahbazian A, Ji S, Boström KI

Abstract

High-density lipoproteins (HDL) have antiinflammatory effects on the vascular endothelium. Because bone morphogenetic proteins (BMPs) are known to be inflammatory mediators, we examined the effect of HDL on BMP signaling. Increasing concentrations of HDL progressively enhanced expression of the activin-like kinase receptor (ALK)1 and ALK2 in human aortic endothelial cells as determined by real-time polymerase chain reaction and immunoblotting. Induction of ALK1 was a result of enhanced ALK2 expression as determined by siRNA interference, and was associated with increased levels of vascular endothelial growth factor (VEGF) and matrix Gla protein (MGP). The HDL-induction of ALK2 was dependent on BMP-signaling, and affected coregulation of the ALK2 gene by the homeodomain proteins MSX2, DLX3, and DLX5, as determined by reporter gene assays, siRNA interference, and chromatin immunoprecipitation. Apolipoprotein A-I transgenic mice, known to have high HDL and inhibition of atherogenesis, exhibited similar changes in aortic gene expression as seen in endothelial cells treated with HDL in vitro. We conclude that HDL benefits the arterial wall by allowing for enhanced ALK1 and ALK2 signaling, resulting in an increase of VEGF and MGP, essential for endothelial cell survival and prevention of vascular calcification, respectively.

MeSH Terms
Activin Receptors, Type I/genetics,metabolism Activin Receptors, Type II/genetics,metabolism Animals Apolipoprotein A-I/genetics Atherosclerosis/etiology,genetics,metabolism,prevention & control Base Sequence Bone Morphogenetic Protein 4/metabolism,pharmacology Bone Morphogenetic Proteins/metabolism Calcium-Binding Proteins/metabolism Cattle Cells, Cultured Endothelial Cells/drug effects,metabolism Extracellular Matrix Proteins/metabolism Humans Lipoproteins, HDL/metabolism,pharmacology Mice Mice, Inbred C57BL Mice, Transgenic Promoter Regions, Genetic RNA Interference RNA, Small Interfering/genetics Signal Transduction/drug effects Vascular Endothelial Growth Factor A/metabolism
Chemicals
Apolipoprotein A-I BMP4 protein, human Bone Morphogenetic Protein 4 Bone Morphogenetic Proteins Calcium-Binding Proteins Extracellular Matrix Proteins Lipoproteins, HDL RNA, Small Interfering VEGFA protein, human Vascular Endothelial Growth Factor A matrix Gla protein ACVR1 protein, human ACVRL1 protein, human Activin Receptors, Type I Activin Receptors, Type II
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Yao Yucheng
Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1679, USA.
Shao Esther S
Jumabay Medet
Shahbazian Ani
Ji Sheng
Boström Kristina I
References (31)
31 references, click to expand
  1. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques.
    Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):1998-2003 PMID: 11742876
  2. Evaluation of cardiovascular risk factors and bone mineral density in post menopausal women undergoing coronary angiography.
    Int J Cardiol. 2008 Dec 17;131(1):66-9 PMID: 18222554
  3. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response.
    J Biol Chem. 2003 Aug 15;278(33):31128-35 PMID: 12766166
  4. Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link?
    Endocrine. 2004 Feb;23(1):1-10 PMID: 15034190
  5. Cardiac outflow tract defects in mice lacking ALK2 in neural crest cells.
    Development. 2004 Jul;131(14):3481-90 PMID: 15226263
  6. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.
    Nature. 1991 Sep 19;353(6341):265-7 PMID: 1910153
  7. Bone morphogenetic protein expression in human atherosclerotic lesions.
    J Clin Invest. 1993 Apr;91(4):1800-9 PMID: 8473518
  8. Immunolocalization of BMP-6, a novel TGF-beta-related cytokine, in normal and atherosclerotic smooth muscle cells.
    Atherosclerosis. 1995 Mar;113(2):153-6 PMID: 7605353
  9. High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells.
    Circulation. 2005 May 31;111(21):2805-11 PMID: 15911702
  10. Bone morphogenetic proteins in vascular calcification.
    Circ Res. 2005 Jul 22;97(2):105-14 PMID: 16037577
  11. Lipid levels and bone mineral density.
    Am J Med. 2005 Dec;118(12):1414 PMID: 16378789
  12. Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype.
    Am J Pathol. 2006 Feb;168(2):629-38 PMID: 16436676
  13. Endothelial and antithrombotic actions of HDL.
    Circ Res. 2006 Jun 9;98(11):1352-64 PMID: 16763172
  14. Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling.
    Mol Cell Biol. 2006 Oct;26(20):7791-805 PMID: 16923969
  15. Regulation of bone morphogenetic protein-4 by matrix GLA protein in vascular endothelial cells involves activin-like kinase receptor 1.
    J Biol Chem. 2006 Nov 10;281(45):33921-30 PMID: 16950789
  16. The new bone biology: pathologic, molecular, and clinical correlates.
    Am J Med Genet A. 2006 Dec 1;140(23):2646-706 PMID: 17103447
  17. BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network.
    J Biol Chem. 2006 Dec 29;281(52):40515-26 PMID: 17060321
  18. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells.
    Blood. 2007 Mar 1;109(5):1953-61 PMID: 17068149
  19. Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium.
    Vasc Health Risk Manag. 2005;1(2):119-29 PMID: 17315398
  20. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis.
    J Cell Sci. 2007 Mar 15;120(Pt 6):964-72 PMID: 17311849
  21. Activin-like kinase receptor 1 (ALK1) in atherosclerotic lesions and vascular mesenchymal cells.
    Cardiovasc Res. 2007 May 1;74(2):279-89 PMID: 17074310
  22. High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory.
    Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1346-53 PMID: 17379837
  23. Autocrine VEGF signaling is required for vascular homeostasis.
    Cell. 2007 Aug 24;130(4):691-703 PMID: 17719546
  24. Bone morphogenic protein antagonists are coexpressed with bone morphogenic protein 4 in endothelial cells exposed to unstable flow in vitro in mouse aortas and in human coronary arteries: role of bone morphogenic protein antagonists in inflammation and atherosclerosis.
    Circulation. 2007 Sep 11;116(11):1258-66 PMID: 17785623
  25. Endothelial expression of endoglin in normocholesterolemic and hypercholesterolemic C57BL/6J mice before and after atorvastatin treatment.
    Can J Physiol Pharmacol. 2007 Aug;85(8):767-73 PMID: 17901886
  26. Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice.
    Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2589-96 PMID: 17932314
  27. Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trial.
    J Clin Endocrinol Metab. 2007 Dec;92(12):4671-7 PMID: 17726081
  28. Cholesterol modulates cellular TGF-beta responsiveness by altering TGF-beta binding to TGF-beta receptors.
    J Cell Physiol. 2008 Apr;215(1):223-33 PMID: 17972267
  29. Proline and gamma-carboxylated glutamate residues in matrix Gla protein are critical for binding of bone morphogenetic protein-4.
    Circ Res. 2008 May 9;102(9):1065-74 PMID: 18369157
  30. Novel homeobox genes are differentially expressed in placental microvascular endothelial cells compared with macrovascular cells.
    Placenta. 2008 Jul;29(7):624-30 PMID: 18514308
  31. Mechanisms of TGF-beta signaling from cell membrane to the nucleus.
    Cell. 2003 Jun 13;113(6):685-700 PMID: 12809600
Article Info
Journal
Arteriosclerosis, thrombosis, and vascular biology
Abbr.
Arterioscler Thromb Vasc Biol
ISSN
1524-4636
Published
2008-12-00
Epub
2008-00-23
Pages
2266-74
Language
English
Region
United States
NLM ID
9505803
PMCID
PMC2709402
Subset
IM
Grants
NHLBI NIH HHS · R01 HL081397-01A1 · United States
NHLBI NIH HHS · R01 HL081397-03 · United States
NHLBI NIH HHS · HL30568 · United States
NHLBI NIH HHS · R01 HL081397 · United States
NHLBI NIH HHS · P01 HL030568 · United States
NHLBI NIH HHS · P01 HL030568-250010 · United States
NHLBI NIH HHS · HL81397 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com